Tempus AI Soars After Gilead Partnership Deal

Tempus AI stock experienced a rise following the announcement of a collaboration deal with Gilead. The partnership signals growing interest in AI-driven solutions within the pharmaceutical and biotech sectors, boosting investor confidence in Tempus AI.